Cyborg | Designer-Babies | Futurism | Futurist | Immortality | Longevity | Nanotechnology | Post-Human | Singularity | Transhuman

Hair Transplant Lecture in Brazil: Regenerative Medicine- PRP and ACell
Dallas hair transplant surgeon, Dr. Sam Lam, speaks at the 5th Brazilian Congress on Hair Restoration, held in Maresias, Brazil, on May 23, 2014, on the subj…

By: Samuel Lam

Go here to see the original:
Hair Transplant Lecture in Brazil: Regenerative Medicine- PRP and ACell – Video

Video Regenerative+Medicine+Workshop+promo+R4 HD
Annual Regenerative Medicine Workshop at Hilton Head, SC. The 2015 meeting will take place May 12-17 at the beautiful Sea Pines resort.

By: IBBGeorgiaTech

See original here:
Video Regenerative+Medicine+Workshop+promo+R4 HD – Video

Through regenerative medicine, your ADRCs can rebuild damaged muscle tissue

In the country, there is a facility identified as the first medical center in South East Asia to offer the most advanced regenerative medical procedures. It utilizes state-of-the-art processing, delivery, and preservation of medical-grade Adipose-Derived Regenerative Cells (ADRCs). Located at Zuellig Bldg. Makati Avenue cor. Paseo De Roxas, Makati City, EA Regenerative Medicine Center of Excellence follows the most stringent clinical protocols, registries and standards of operations.

The center makes use of the Celution System from Cytori Therapeutics USA. Their process involves the extraction of unwanted fats derived from the patients own body and isolating the healthy therapeutic cells which can then be administered for the treatment of a whole range of age-related conditions like cardiovascular diseases, orthopedics, muscle, ligament and soft tissue injuries, gastrointestinal disorders, pain management, and procedures for plastic and reconstructive surgery that ensure the safest, most natural, and efficient healing process available to modern health science.


There are stem cells throughout the human body, but theyre rare and difficult to access. The problem facing companies interested in treatment models is this: in order to get therapeutic numbers, you have to grow the stem cells in cultures.

This process fundamentally transforms the cells, based on their time in culture. Under existing FDA regulations, it also effectively makes any treatment derived from a drug, with all the development costs, regulatory hurdles and expenses to get over before having a product to bring to patients.

Theres really not a tissue in the body where, with impunity and effectively no risk, you can take a liters worth from anybody, says David Oxley, Cytori vice president.

But there is your body fatthe thing most of us hate wearing around our waistlines the most.

Fat tissue is one of the sources of therapeutic levels of stem cells. Theres no comparison, says Dr. Eder Garcia Dizon, managing director of EA Regenerative Medicine Center of Excellence. Even bone marrow and cord blood as source pales in comparison from a volume and number of cells perspective.

The Celution system was devised by Cytori to get those cells from the patients fat tissue to their targeted area of need as quickly and efficiently as possible.

Read more from the original source:
Your fat can heal your heart

Neuroscience Daniel Medicine Kraft and Introduction to
Daniel Kraft, MD, speaking about Stem Cells Regenerative Medicine at Singularity University's Exponential Medicine Conference. FutureMed Executive Director and Singularity University Medicine…

By: carolina

Read more:
Neuroscience Daniel Medicine Kraft and Introduction to – Video

The Alliance for Regenerative Medicine , the international organization representing the interests of the advanced therapies and regenerative medicine community, supports the NIH decision announced today …

Originally posted here:
The Alliance for Regenerative Medicine Supports the NIH Decision to Change Role of Recombinant DNA Advisory Committee

La Mirada, CA (PRWEB) May 22, 2014

Healthpointe Medical Group is proud to announce that they are offering Regenerative Medicine Services at their facilities located throughout Southern California. Regenerative Medicine is a rapidly growing field that is aimed at restoring and/or replenishing the normal function of tissues that are damaged or otherwise affected by diseases. Through this program, Healthpointe provides simple, effective, and non-invasive Wound Care options to treat pain and various complex and non-healing wounds. This program is focused on providing patients with non-surgical approaches to treating a patients pain and providing state-of-the-art wound care. Healthpointes multidisciplinary team of physicians is ready to deliver quality wound care solutions to their patients. Their doctors adhere to the motto of delivering quality care to everyone, and they do so by offering customized treatment plans to better fit patients specific needs. Services under the Regenerative Medicine include:

Other Wound Care Services offered at Healthpointe:

These services may also be used in conjunction with surgical procedures to augment recovery time after surgery by enhancing the patients healing process. Regenerative Medicine services, along with the other Wound Care Services, are also known to decrease formation of scar tissues, especially after undergoing complex surgeries. Patients who are affected by soft tissue damage and difficult-to-heal wounds may finally find some resolution to their condition thanks to the new Regenerative Medicine services at Healthpointe. Healthpointes services are offered during regular business hours: Monday-Friday 9-6. For more information, contact Healthpointe at 844-887-7882 or visit the Healthpointe Website.

Go here to read the rest:
Regenerative Medicine Services Are Now Being Offered at Healthpointe

LONDON, United Kingdom — via PRWEB – Aging Analytics & The London Regenerative Medicine Network have co-published 'Investing in Regenerative Medicine: Technology Analysis & Market Outlook', a 106 page …

Read the original:
Live Long & Prosper? A New Report Highlights Economic & Health Benefits of A Growing Regenerative Medicine Sector

The Alliance for Regenerative Medicine and the American Society of Gene & Cell Therapy today announced their partnership. ARM's new Gene and Gene-Modified Cell Therapy Section brings together the leading …

Originally posted here:
Gene Therapy Section Formed Within the Alliance for Regenerative Medicine

RepliCel Life Sciences Inc. a clinical stage regenerative medicine company focused on the development of autologous cell therapies, is pleased to announce that its RCH-01 licensing partner, Shiseido, celebrated …

Go here to read the rest:
RepliCel Life Sciences' Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance …

Regenerative medicine company Avita Medical Limited is pleased to announce that Mr Lou Panaccio, a successful healthcare businessman with extensive experience progressing companies from concept to commercialisation, …

View original post here:
Avita Medical Appoints New Chairman

This post is sponsored by DIA.

Regenerative medicines and the latest regulatory issues surrounding them will be a hot topic for discussion at the DIA 2014 50th Annual Meeting. This years Annual Meeting will be in San Diego from June 15 to 19 and will feature a session titled Pioneering Regenerative Medicine: Trends in Regulations for New Therapy, under the Nonclinical and Translational Development/Early Phase Clinical Development track.

The session, to be held on June 16 from 8:30-10:00 AM, will introduce the first clinical research of induced pluripotent stem (iPS) cell products in Japan and review the current regulatory status and governmental efforts surrounding regenerative medicine. Speakers will also identify issues in the application of the new technology and discuss possible solutions.

iPS cells hold great promise in the field of regenerative medicine because they can propagate indefinitely, as well as give rise to every other cell type in the body such as neurons, heart, pancreatic, and liver cells, and therefore represent a single source of cells that could be used to replace those lost to damage or disease. iPS cell technology was pioneered by Shinya Yamanaka of Kyoto, Japan, who was awarded the 2012 Nobel Peace Prize for the discovery alongside Sir John Gurdon.

The session will be chaired by Shinji Miyake, PhD, Professor of the Center for Clinical Research at Keio University School of Medicine in Japan.

The DIA 2014 50th Annual Meeting: Celebrate the Past Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

This years event celebrates DIAs 50th Anniversary and will feature 260+ educational offerings over 21 tracks, 450+ exhibiting companies, over 125 representatives from global regulatory agencies, and much more. The meeting provides participants with a valuable opportunity to network with professionals from around the world, share knowledge, and build new relationships.

Find out more about DIA 2014 50th Annual Meeting at

Get our daily newsletter or follow us.

Please enter your email below:

See the article here:
Introducing pioneering regenerative medicine

TAMPA BAY, Fla., May 19, 2014 /PRNewswire-iReach/ — Regenerative medicine, a developing practice which maximizes the body's innate ability to restore vital functions, is an emerging technique in the realm of cosmetic procedures. But regenerative medicine is not only coveted for its growing reputation as a fountain of youthtechnological advances have also been discovered that could possibly …

Visit link:
Skinspirations Expands Services–Regenerative Medicine Tops Client Demands, Forges New Healthcare Trail

BioCardia, Inc., a leader in cardiovascular regenerative medicine, today announced the presentation by Juventas Therapeutics of their positive four-month results for their STOP-HF

See the article here:
Phase II STOP-HF Trial Shows Excellent Safety Profile, Supports Efficacy for Juventas JVS-100 as Delivered by …

Juventas Therapeutics, Inc.,a private clinical-stage company developing a drug-based approach to regenerative medicine, today presented top-line interim data from a Phase II study

Read more:
Juventas Therapeutics Data Demonstrates Significant Structural, Clinically Meaningful Benefit in Patients with …

Enliven: Journal of Stem Cell Research Regenerative Medicine
Enliven: Journal of Stem Cell Research Regenerative Medicine is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments…

By: enlivenarchive

Read more:
Enliven: Journal of Stem Cell Research & Regenerative Medicine – Video

BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine Cell-Based Assays Part I
Introduction to the 2014 BioLamina Symposium on Biorelevant Approaches to Regenerative Medicine Cell-Based Assays by Prof. Karl Tryggvason. He talks about …

By: BioLamina

BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine & Cell-Based Assays Part I – Video

Meet HSCI's Amar Sahay, PhD
Amar Sahay, PhD, is an Assistant Professor at the Center for Regenerative Medicine and the Department of Psychiatry at Massachusetts General Hospital, Harvar…

By: harvardstemcell

More here:
Meet HSCI’s Amar Sahay, PhD – Video

BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine Cell-Based Assays Part VI
PhD Anna Falk from the Karolinska institute talks about The role of neural stem cells in neurodevelopmental disorders For psychiatric diseases, which later in life manifest in impairment of…

By: BioLamina

More here:
BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine & Cell-Based Assays Part VI – Video

Platelet rich plasma in regenerative medicine

By: osama ashmawy

Read the original:
Platelet rich plasma in regenerative medicine – Video

BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine Cell-Based Assay Part III
Sergey Rodin walks us through his new Nature communications article Laminin-521 and -511 are versatile substrata for long-term self-ren…

By: BioLamina

More here:
BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine & Cell-Based Assay Part III – Video

FireFox! Start Your Own Web Hosting Company
Web Hosting Advertise Here $10 a Month Affordable web-hosting
Pierre Teilhard De Chardin

Designer Children | Prometheism | Euvolution | Transhumanism

Sign up below for the Prometheism / Designer Children Discussion Forum

Subscribe to prometheism-pgroup

Powered by